Nippon India Nifty Pharma ETF - Growth Plan vs Motilal Oswal Gold and Silver Etfs Fund of Funds Direct Growth
NAV, returns and costs — not a recommendation.
 Nippon India Nifty Pharma ETF - Growth Plan |  Motilal Oswal Gold and Silver Etfs Fund of Funds Direct Growth | |
|---|---|---|
| NAV | ₹27.1122 | ₹31.1415 |
| NAV date | 2026-08-18 | 2026-08-18 |
| 1 year | +19.49% | +64.37% |
| 3 year (p.a.) | +20.35% | +39.10% |
| 5 year (p.a.) | +14.55% | +34.38% |
| Expense ratio | 0.18% | 0.76% |
| Fund size | ₹1,622.31 Cr | ₹2,863.07 Cr |
| Risk | Very high | Very high |
| Category | Etfs | Fund of Funds Domestic Gold and Silver |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.